Print this page    •   Back to Web version of article

Medical News
Chinese Company Develops New Drug to Fight HIV/AIDS

July 11, 2005

A Chinese pharmaceutical maker has developed a new HIV drug that aims to block the virus from entering cells, the China Daily reported today. FusoGen Pharmaceuticals is currently testing the drug, a fusion inhibitor, in clinical trials. Zhou Genfa, FusoGen's chairperson, said the drug is modeled after the U.S.-developed Fuzeon -- the first drug in a new class of fusion inhibitors -- but employs a different molecular modeling. The drug, which has been registered as a new medicine with China's State Food and Drug Administration, will likely hit the market at the end of next year and will be priced "significantly" lower than Fuzeon, which can cost $20,000 per patient per year, said Zhou.

Back to other news for July 11, 2005

Excerpted from:
Agence France Presse
07.11.05




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. You can find this article online by typing this address into your Web browser:
http://www.thebody.com/content/art25305.html

General Disclaimer: TheBody.com is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through TheBody.com should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.